Chim C. Lang

Active 1992–2025

164
Papers
21,078
Citations
82
h-index
159
i10-index

Citations

Citations per year for Chim C. Lang1972: 1 citations1993: 1 citations1994: 11 citations1995: 4 citations1996: 32 citations1997: 27 citations1998: 45 citations1999: 35 citations2000: 42 citations2001: 47 citations2002: 52 citations2003: 36 citations2004: 80 citations2005: 46 citations2006: 80 citations2007: 103 citations2008: 91 citations2009: 117 citations2010: 93 citations2011: 111 citations2012: 97 citations2013: 130 citations2014: 116 citations2015: 117 citations2016: 108 citations2017: 118 citations2018: 115 citations2019: 475 citations2020: 782 citations2021: 798 citations2022: 650 citations2023: 529 citations2024: 876 citations2025: 506 citations2026: 21 citations1973–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,068 citing papers, 16.9% of this breakdownUnited Kingdom: 1,244 citing papers, 10.2% of this breakdownChina: 787 citing papers, 6.4% of this breakdownItaly: 718 citing papers, 5.9% of this breakdownGermany: 659 citing papers, 5.4% of this breakdownNetherlands: 571 citing papers, 4.7% of this breakdownCanada: 568 citing papers, 4.6% of this breakdownFrance: 397 citing papers, 3.2% of this breakdownSweden: 344 citing papers, 2.8% of this breakdownSpain: 321 citing papers, 2.6% of this breakdownAustralia: 313 citing papers, 2.6% of this breakdownGreece: 263 citing papers, 2.1% of this breakdown
0%16.9%Other 32.6%

Fields

  • Medicine83.1%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Immunology and Microbiology1.6%
  • Nursing1.4%
  • Neuroscience1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other3.1%

Topics

  • Heart Failure Treatment and Management7.9%
  • Cardiovascular Function and Risk Factors7.1%
  • Diabetes Treatment and Management3.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2%
  • Metabolism, Diabetes, and Cancer1.9%
  • Cardiovascular Disease and Adiposity1.5%
  • Other75.9%

Coauthors

All papers

Open in search
  1. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul W X Foley, Fraser J Graham, Alan G. Japp, Rebecca Lane, Ninian N. Lang, Andrew Ludman, Iain C. Macdougall, Pierpaolo Pellicori, Robin Ray, Michele Robertson, Alison Seed, Ian Ford, Nicholas A. Boon, Shannon Amoils, Callum Chapman, Thomas G Diness, John McMurray, Richard Mindham, Pamela Sandu, Claes Christian Strom, Maureen Travers, Robert Wilcox, Allan D. Struthers, Patrick B. Mark, Christopher J. Weir, Elena Cowan, Charlotte Turner, Rosalynn Austin, Paula Rogers, Badri Chandrasekaran, E Fraile, Lynsey Kyeremeh, Lorraine McGregor, Joanna Osmanska, Barbara Meyer, Faheem Ahmad, Jude Fisher, Christina Summersgill, Katarzyna Adeniji, Rajkumar Chinnadurai, Lisa Massimo, Clare S. Hardman, Daisy Sykes, Sarah Frank, Simon Smith, Mohamed Anwar, Beth Whittington, Vennessa Sookhoo, Sinéad Lyons, Janet Middle, Kay Housley, Andrew L. Clark, Jeanne Bulemfu, Christopher Critoph, Victor Chong, Stephen J. Wood, Benjamin R. Szwejkowski, Chim C. Lang, Jackie Duff, Susan M. MacDonald, Rebekah Schiff, Patrick Donnelly, Thuraia Nageh, Swapna Kunhunny, Roy S. Gardner, Marion McAdam, Elizabeth McPherson, Prithwish Banerjee, Eleanor Sear, Nigel Edwards and 91 more - The Lancet 2022 cited by 372

  2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Devendra K Agarwal, Maher Agha, Azazuddin Ahmed, Petteri Ahtiainen, Elmar Aigner, Naik Ajay, Norsiah Ali, Amer Al-Karadsheh, Roy Allison, Dale C Allison, Diana Alpenidze, Yuksel Altuntas, Ayham Al-Zoebi, Roy Ambuj, John Amerena, Robert J Anderson, Toshiaki Ando, Robert Andrews, Elizaveta Antonova, Karl-Friedrich Appel, Flávia B Arantes, Mustafa Araz, Yaron Arbel, José L Arenas León, Georgia Argyrakopoulou, Mehrdad Ariani, Maria A Arias Mendoza, Ahmed A Arif, Jaspal Arneja, Vanita R Aroda, Louis J Aronne, Margaret Arstall, Njaimeh Asamoah, Milika Asanin, Hanid Audish, Rodica Avram, Aysha Badat, Corin V Badiu, Wa'el Bakdash, Okan S Bakiner, Vuyokazi N Bandezi, Liew H Bang, Sandeep Bansal, Marietta Baranyai, Olga Barbarash, Mark Barber, Otis Barnum, Gilles Barone Rochette, Amir Bashkin, Seth Baum, Harold E Bays, Alberto E Bazzoni Ruiz, Maciej Beckowski, Yaswin Beerachee, Srikanth Bellary, Lidia Belousova, Martin Berk, Marc Bernstein, Cesare Berra, Isaac Beshay, Ajit Bhagwat, Arti Bhan, William C Biggs, Liana Billings, Fahed Bitar, Bradley Block, Simona Bo, Pawel Bogdanski, Olga O Bolshakova, Alla A Boshchenko and 732 more - The Lancet 2024 cited by 230

  3. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

    Authors: , , , , , , , , , , , , , , , - Circulation Research 2016 cited by 721

  4. The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 cited by 281

  5. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

    Authors: , , , , , , , , , , , , , , - The Lancet 2005 cited by 2,897

  6. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 306

  7. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 216

  8. A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial

    Authors: , , , , , - European Heart Journal 2020 cited by 256

  9. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eugenio B Reyes, Bambang Budi Siswanto, Wataru Shimizu, Shu Zhang, Adriaan A. Voors - The Lancet 2019 cited by 247

  10. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

    Authors: , , , , , , , , , , , , , , , , - European Heart Journal 2017 cited by 403

  11. Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure

    Authors: , , , , , - Circulation 2020 cited by 251

  12. Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandeep S Hothi, Nicholas A. Boon, Sanjay Prasad, Niall Keenan, Dana Dawson, Thomas A. Treibel, Manish Motwani, Christopher A. Miller, Nicholas L. Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E. Newby, Marc R. Dweck, EVOLVED investigators, Kush Patel, Mervyn Andiapen, Lucinda Wynne, Hunaid A. Vohra, Jodie Hussain, Kelly Patel, Stephen Dorman, Laura Gallego‐Yerga, Jonaifah Ramirez, Emily Redman, Sofia Matia, Madelaine Ocampo, Annaliza Sevilliano, Gracie Maloney, Amanda Solesbury, Steven Church, Lauren Kittridge, Jovita Rebong, Jacqueline Colnet, Johannes Pintacasi, James H. Morrissey, Aoife Tipping, Stephanie Hunt, Amy Raynsford, Daniel L. Cooke, Dan Sado, Jonathan Byrne, Abigail Knighton, Jonathan Breeze, Michail Sionas, J. Crawford Crowe, Maju Jose, Thabitha Charles, Anu Mary Oommen, Victoria Clegg, April Edwards, Adele Trueman, Rajeev Padjama, Suzanne Higson, Martin Sherwood, Sarah Mackie, Anita McNab, Preetha Mathew, Akhila Muthuswamy, Sujata Blane, Sheetal Crasta, Kathryn Walker, Anne Ankers, Philip McGrouther, Dean J. Miller, Denise O'Donell, Melanie Tolson, Anne Firor Scott and 86 more - JAMA 2024 cited by 123

  13. Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 222

  14. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

    Authors: , , , , , , , , , , , , , , , - European Journal of Heart Failure 2021 cited by 145

  15. Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial

    Authors: , , , , , , , , , , , , , - Diabetes Care 2020 cited by 201

  16. Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

    Authors: , , , , , , , , , , , - JACC Heart Failure 2022 cited by 76

  17. Clinical Role of CA125 in Worsening Heart Failure

    Authors: , , , , , , , , , , , , , , - JACC Heart Failure 2020 cited by 113

  18. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients with New-Onset or Worsening Heart Failure with Reduced and Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , - ESC Heart Failure 2021 cited by 89

  19. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Cardiology 2018 cited by 203

  20. Insulin-Like Growth Factor Binding Protein 7 (IGFBP7), a Link Between Heart Failure and Senescence

    Authors: , , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2022 cited by 53

  21. A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHF

    Authors: , , , , , , , , , , , , , , , - European Journal of Heart Failure 2016 cited by 204

  22. Repurposing Metformin for Cardiovascular Disease

    Authors: , - Circulation 2018 cited by 148

  23. Pulmonary Arterial Hypertension: Pathophysiology and Treatment

    Authors: , , , - Diseases 2018 cited by 178

  24. Selenium and Outcome in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 cited by 151